GlucoStabilizer outperforms paper-based protocol for insulin management.
Read More
GlucoStabilizer used to optimize glycemic targets for different patient populations which allowed for lower incidence of hypoglycemia.
Read More
GlucoStabilizer successfully used in the management of DKA with the avoidance of hypoglycemia.
Read More
GlucoStabilizer is efficacious and safe for treatment of patients with a primary diagnosis of DKA when compared to provider-driven insulin dosing.
Read More
GlucoStabilizer used in obstetrics can improve intrapartum glycemic management without increasing hypoglycemia in women with both pregestational and gestational diabetes mellitus that is treated with an insulin infusion.
Read More
GlucoStabilizer successfully manages patient’s blood glucoses in the intensive care unit of an acute care facility.
Read More
Converting from a paper-based protocol to GlucoStabilizer for intensive insulin therapy resulted in superior control of hyperglycemia and marked decrements in the incidence of hypoglycemia and glycemic variability.
Read More
Patients whose intensive insulin infusions were managed using the GlucoStabilizer software program, as compared to a traditional paper protocol achieved sustained tighter glycemic control.
Read More
GlucoStabilizer provides a safe and effective way to treat acute hyperglycemia in the pregnant population.
Read More
Glycemic control targeted to a lower glucose range was achieved using GlucoStabilizer and the risk of hypoglycemia experienced can be minimized.
Read More
Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.
Read More